The Latest Cardiac and Vascular News
IRVINE, CA, UNITED STATES, August 31, 2026 /EINPresswire.com/ — Innova Vascular, Inc., a medical technology company developing innovative endovascular solutions for the treatment of vascular thromboembolism, today announced the completion of patient enrollment in the TRUST pivotal Investigational Device Exemption (IDE) clinical study evaluating the safety and effectiveness of the Laguna® Thrombectomy […]
Following its May 2026 CE mark, Sentante is deploying first in the specialties its platform was built to serve, and where the multi-modal data that trains endovascular physical AI accumulates from the first commercial case KAUNAS, Lithuania, Aug. 25, 2026 /PRNewswire/ — Sentante, the…
PALM SPRINGS, Calif., Aug. 24, 2026 /PRNewswire/ — The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are presented during The VEINS and VIVA 2026, taking place October 3-6 at Bellagio Las Vegas. The highly anticipated late-breaking…
— Novel coils from Embolization, Inc., demonstrate consistent performance across a range of cases — BOULDER, Colo., Aug. 20, 2026 /PRNewswire/ — The novel, radiopaque, polymer-based embolic coil from Embolization, Inc., has now topped 125 implants nationwide, demonstrating continued…
MENLO PARK, Calif.–(BUSINESS WIRE)– #TFX–Jupiter Endovascular appoints renowned interventional cardiologist Dr. Catalin Toma as Chief Medical Officer
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval. DALLAS, Aug. 13, 2026 /PRNewswire/ — Vesalio, a global leader in vascular intervention, today announced that the U.S. Food and Drug Administration (FDA)…
The U.S. pivotal study will evaluate FastWave’s electric IVL system in patients with peripheral artery disease. MINNEAPOLIS, Aug. 11, 2026 /PRNewswire/ — FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, has received FDA approval of its Investigational Device Exemption (IDE) application, which clears the company to begin a U.S. pivotal trial of its ArteroTM electric IVL […]
Drive-side force sensing and a 1:1 motion-mimicking interface make every procedure a training-grade record of expert clinical skill KAUNAS, Lithuania, July 23, 2026 /PRNewswire/ — Sentante, the medical robotics company building a haptic, device-agnostic platform for remote vascular…
FLAGSTAFF, Arizona (July 7, 2026)—W. L. Gore & Associates’ medical business (“Gore”) announced today that the U.S. Food and Drug Administration has approved updated labeling for the GORE® EXCLUDER® AAA Endoprosthesis and the GORE® EXCLUDER® Conformable AAA Endoprosthesis, adding real‑world clinical evidence that supports the use of EVAR devices in appropriately selected patients with ruptured abdominal aortic […]
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of the only commercially available volume‑expanding shape memory polymer for endovascular embolization, announced today that it has completed enrollment in the AAA‑SHAPE Pivotal Trial, a prospective, multicenter, randomized, open‑label controlled study evaluating the safety and effectiveness of the IMPEDE‑FX RapidFill® Device when used alongside endovascular aneurysm repair, or EVAR, to improve abdominal aortic aneurysm (AA
